| Dr Scott Michael Sech, MD | |
|
1100 Tunnel Rd, Asheville, NC 28805-2576 | |
| (828) 298-7911 | |
| Not Available |
| Full Name | Dr Scott Michael Sech |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 1100 Tunnel Rd, Asheville, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215921465 | NPI | - | NPPES |
| 12075 | Other | NC | BCBS OF NC |
| 19-71374 | Other | UNITED HEALTH CARE | |
| 340018021 | Other | RAILROAD MEDICARE | |
| 8912075 | Medicaid | NC | |
| 3264792002 | Other | CIGNA HEALTHCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 9900345 (North Carolina) | Primary |
| 208800000X | Urology | NUCC12X (North Carolina) | Secondary |
| Entity Name | Mission Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114150190 PECOS PAC ID: 0749326106 Enrollment ID: O20100313000054 |
News Archive
Improved patient-oriented research in Europe will benefit European citizens and the European medical industry and facilitate the transfer of scientific discoveries from the laboratory bench to the bedside. For Europe and for the rest of the world this effort will be of great importance for the quality of life of individuals and the wellbeing of society as a whole.
The impact of antibiotic misuse has far-reaching consequences in healthcare, including reduced efficacy of the drugs, increased prevalence of drug-resistant organisms, and increased risk of deadly infections. A new study featured in the February issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, found that many patients with Clostridium difficile infection (C. difficile) are prescribed unnecessary antibiotics, increasing their risk of recurrence of the deadly infection.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.
A study exploring cross-cultural differences in knowledge and attitudes towards COVID-19 reveals that people in Europe had the least knowledge of COVID-19 and lowest tendency to care about the coronavirus, while people in the United States had the lowest tendency to comply with public health restrictions.
› Verified 6 days ago
| Entity Name | Mission Hospitals Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760741623 PECOS PAC ID: 0648189969 Enrollment ID: O20120821000771 |
News Archive
Improved patient-oriented research in Europe will benefit European citizens and the European medical industry and facilitate the transfer of scientific discoveries from the laboratory bench to the bedside. For Europe and for the rest of the world this effort will be of great importance for the quality of life of individuals and the wellbeing of society as a whole.
The impact of antibiotic misuse has far-reaching consequences in healthcare, including reduced efficacy of the drugs, increased prevalence of drug-resistant organisms, and increased risk of deadly infections. A new study featured in the February issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, found that many patients with Clostridium difficile infection (C. difficile) are prescribed unnecessary antibiotics, increasing their risk of recurrence of the deadly infection.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.
A study exploring cross-cultural differences in knowledge and attitudes towards COVID-19 reveals that people in Europe had the least knowledge of COVID-19 and lowest tendency to care about the coronavirus, while people in the United States had the lowest tendency to comply with public health restrictions.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Michael Sech, MD 100 Victoria Rd, Asheville, NC 28801-4812 Ph: (828) 254-8883 | Dr Scott Michael Sech, MD 1100 Tunnel Rd, Asheville, NC 28805-2576 Ph: (828) 298-7911 |
News Archive
Improved patient-oriented research in Europe will benefit European citizens and the European medical industry and facilitate the transfer of scientific discoveries from the laboratory bench to the bedside. For Europe and for the rest of the world this effort will be of great importance for the quality of life of individuals and the wellbeing of society as a whole.
The impact of antibiotic misuse has far-reaching consequences in healthcare, including reduced efficacy of the drugs, increased prevalence of drug-resistant organisms, and increased risk of deadly infections. A new study featured in the February issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, found that many patients with Clostridium difficile infection (C. difficile) are prescribed unnecessary antibiotics, increasing their risk of recurrence of the deadly infection.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.
A study exploring cross-cultural differences in knowledge and attitudes towards COVID-19 reveals that people in Europe had the least knowledge of COVID-19 and lowest tendency to care about the coronavirus, while people in the United States had the lowest tendency to comply with public health restrictions.
› Verified 6 days ago
Dr. John George Cargill Iii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Doctors Park, Asheville, NC 28801 Phone: 828-253-5314 Fax: 828-254-5216 | |
Dr. Ricky L Bare, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Doctors Park, Asheville, NC 28801 Phone: 828-253-5314 Fax: 828-254-5216 | |
Bruce Griffey Armstrong, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1 Doctors Park, Asheville, NC 28801 Phone: 828-253-5314 Fax: 828-254-5216 | |
Dr. Alan David Friedman I, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 100 Victoria Rd, Asheville, NC 28801 Phone: 828-254-8883 Fax: 828-253-2024 | |
Dr. Brian Louis Cohen, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Victoria Rd, Asheville, NC 28801 Phone: 828-254-8883 Fax: 828-253-2024 | |
Dr. Karen Renee Frye, M.D. Urology Medicare: Medicare Enrolled Practice Location: 100 Victoria Rd, Asheville, NC 28801 Phone: 828-254-8883 Fax: 828-253-2024 |